mRNA-4157

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mRNA-4157, covering 2025-12-03 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors [Phase 1]

See pricing